Today, the Secretary of Health and Human Services (HHS) Alex M. Azar II appointed Norman E. Sharpless, MD, to be the acting Commissioner of the U.S. Food and Drug Administration (FDA). He will be replacing the current FDA Commissioner, Scott Gottlieb, MD, who announced his resignation on March 5.
Dr. Sharpless is currently the Director of the National Cancer Institute, the largest division within the National Institutes of Health. He previously served as Director of the University of North Carolina Lineberger Comprehensive Cancer Center and was a practicing oncologist specializing in leukemia. Additionally, his research focus has been on the roll the cell cycle plays in cancer and aging.
He has authored more than 100 research papers, is an inventor with 10 patents, and is a member of the nation's oldest honor society for physician-scientists, the American Society of Clinical Investigation.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.